Ostrum Asset Management’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$318K	Buy	961 +14	+1%	+$4.76K	0.02%	409
2025 Q4	$377K	Buy	947 +566	+149%	+$250K	0.02%	406
2025 Q3	$174K	Sell	381 -13	-3%	-$5.29K	0.01%	501
2025 Q2	$128K	Sell	394 -12	-3%	-$3.32K	0.01%	529
2025 Q1	$110K	Sell	406 -11	-3%	-$2.83K	0.01%	563
2024 Q4	$98.1K	Sell	417 -3,986	-91%	-$1.05M	0.01%	592
2024 Q3	$1.21M	Sell	4,403 -1,339	-23%	-$349K	0.1%	281
2024 Q2	$1.4M	Sell	5,742 -447	-7%	-$70.6K	0.12%	256
2024 Q1	$925K	Hold	6,189	–	–	0.07%	356
2023 Q4	$1.18M	Buy	6,189 +5,734	+1,260%	+$977K	0.1%	283
2023 Q3	$80.6K	Sell	455 -4	-0.9%	-$763	0.01%	641
2023 Q2	$87.2K	Buy	459 +1	+0.2%	+$198	0.01%	617
2023 Q1	$91.7K	Buy	+458	New	+$96.3K	0.01%	603
2019 Q1	–	Sell	-4,219	Closed	-$308K	–	145
2018 Q4	$308K	Buy	+4,219	New	+$325K	0.12%	144